If you want to prevent Alzheimer’s, researchers have good news for you. They’ve recently found an easy step you can take to help prevent amyloid beta plaques from building up. And this step may even be something you’re already doing.
You probably know that the buildup of amyloid beta plaques contributes significantly to Alzheimer’s disease. So one way to help avoid the disease is to get brain cells to move waste out of the brain as efficiently as possible.
Believe it or not, our cells contain their own “garbage men,” called lysosomes. Lysosomes are responsible for removing debris from the cells. And this can include amyloid beta. So kicking those lysosomes into high gear can really help the brain.
In a mouse model, researchers found a simple way to stimulate lysosomes: aspirin. Sure enough, the lysosomes did a better job of removing plaque when the mice received a daily dose.
How to beat almost any health problem... by rejuvenating every single cell in your body!
This European breakthrough can reverse the effects of aging in your body's cells. Studies show it leads to healthier cholesterol, a sharper memory, a stronger liver and more.
Click Here To Learn More
Many people already take a low daily dose of aspirin to help prevent cardiovascular disease. This research indicates that those who do may be getting an additional benefit to their brains.
Talk to your doctor if you’d like to start a daily aspirin regimen. It’s not always a good idea to combine aspirin with other medications, so seek advice if you’ve got a prescription or two already.
Some people also find that aspirin irritates their stomach. If aspirin isn’t a good fit for you for any reason, you can try Reduloxin instead. This natural anti-inflammatory contains natural ingredients that have been shown to also help protect the brain from amyloid beta plaque buildup.
Better Health and Living for Women,
Sujyoti Chandra, Malabendu Jana, Kalipada Pahan. Aspirin induces Lysosomal biogenesis and attenuates Amyloid plaque pathology in a mouse model of Alzheimer's disease via PPARa. The Journal of Neuroscience, 2018; 0054-18 DOI: 10.1523/JNEUROSCI.0054-18.2018.